Cai et al. demonstrated that in RCC, TIM-3 expression was associated with infiltration of dysfunctional CTCLs and blockage of TIM-3 pathway in enhanced IFN-γ production and enhanced antitumor immunity[63]. This evidence concerns the gene HAVCR2 and renal cell carcinoma.